The suspicion that “the involvement of specific IgE allergy in the pathogenesis of AD might be simply epiphenomenon” was driven by the observation that omalizumab, an anti-IgE biologic, is effective only in some patients, even if they are IgE-allergic AD patients [7,58]. Here, IGHE is linked to Alzheimer disease.